RE: Nice Kipper24 Oct 2023 10:43
Pwil you played the odds, news is due, but in fairness to the abuse you have received you did make it sound like you had inside info rather than just a guess. You should know this is Hemo, unbounded optimism and enthusiasm is NOT allowed here, only negative unlimited trolling is allowed. For what its worth your guess was not unreasonable and I believe news IS due imminently, but I wont set a date on it:
CAR-T - The obvious point is FDA approved the lift hold plan 40 days ago, one step of this as per the RNS was appointment of Prevail as CMO and with this a statement of intent to start trials in 2023. Clearly Prevail knew the timeline to complete the steps and were confident it could be achieved in 1-2 months.
CBR - Tick Tock on this one, so far past update that its a running joke, update could come any time, personally I feel an update would have come already if Hemo were clinical and its purely Vlad having lack of resources to update. However what we do know is Prevail were seeking private investment in BAIT for CBR recently, if this bears fruit it will be a cash injection and thus market sensitive and an RNS will be mandatory. How long do people think those private investors are going to want to wait before putting pen to paper? Its been about a month already, we are in that window.
CDX - Yet another spoke in the wheel, been hearing negotiations have been ongoing for past 2 years, other party still have not gone away, not expecting anything imminently but would be foolish to discount.
Anyway, as Vlad often says, READ the RNS, he stands by them and is quick to say THAT is the only source of information you can trust. There are no leaks, no inside information. If the RNS says the FDA have accepted the Plan, if the RNS says Prevail are onboard to start trials AIMING for 2023.
EVERYTHING here changes when Hemo are clinical. Hemogenyx move from Pre-Clinical lists to clincal
Hemogenyx have approval from FDA to treat patients
HOPEFULLY Hemogenyx ACTUALLY become a "Life Saving Company"
Vlad is free to rapidly advance CBR and CDX
The increased visibility and progress will provide a much higher mCap and allow significantly more capital to be raised at much higher SP and via other direct investment/grants/licencing deals allowing a significant ramp up in research and development. Speeding up updates and progress.
This period we are in this waiting period before the next news? Its frustrating, its like nails on a chalkboard. But its ONLY like that because we KNOW what we are waiting for, its like dangling a piece of meat in front of a hungry dog, we are salivating, but its coming.
Sign In
Follow the stocks
